| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Dec'13 | Dec'12 | Jun'12 | Dec'11 | Jun'11 |
|---|---|---|---|---|---|---|---|---|---|---|
Expenses | ||||||||||
Research and development | ||||||||||
-3,662 | -7,132 | -5,003 | 3,360 | 2,555 | -2,119 | 2,342 | 1,550 | - | 1,051 | - |
General and administrative | ||||||||||
-4,736 | -4,041 | -3,317 | 2,853 | 2,168 | -3,134 | 3,952 | 1,154 | - | 241 | - |
Revenues | ||||||||||
- | - | - | - | - | - | - | - | 0 | - | 0 |
Professional Fees | ||||||||||
- | - | - | - | - | - | - | - | 11 | - | 10 |
Other Selling General and Administrative | ||||||||||
- | - | - | - | - | - | - | - | 7 | - | 22 |
Operating expenses | ||||||||||
-8,398 | -11,174 | -8,320 | 6,214 | 4,724 | -5,253 | 6,294 | 2,705 | 18 | 1,292 | 33 |
Other (income) loss | ||||||||||
Change in fair value of derivative liability | ||||||||||
-433 | -60 | -245 | 2,341 | 627 | -11,529 | 1,324 | 318 | - | 0 | - |
Derivative liability issue costs | ||||||||||
126 | - | - | - | - | - | - | - | - | - | - |
Loss on exchange of warrants | ||||||||||
- | - | - | - | -249 | 0 | - | - | - | - | - |
Issuance of shares to Valent for future royalty reduction | ||||||||||
- | - | - | - | - | - | 598 | 0 | - | - | - |
Change in fair value of derivative liability due to tender offer | ||||||||||
- | - | - | - | - | - | 0 | 0 | - | - | - |
Derivative issuance costs | ||||||||||
- | - | - | - | - | - | 2,713 | 24 | - | 0 | - |
Foreign exchange (gain) loss | ||||||||||
17 | 57 | 7 | - | -23 | 22 | -3 | 18 | - | -18 | - |
Change in fair value of derivative liability due to change in warrant terms | ||||||||||
- | - | - | -295 | -23 | 111 | - | - | - | - | - |
Foreign exchange loss | ||||||||||
- | - | - | 13 | - | - | - | - | - | - | - |
Interest income | ||||||||||
-60 | -33 | -0 | -0 | - | - | - | - | - | - | - |
Interest expense | ||||||||||
- | - | - | - | 2 | -8 | 8 | 7 | - | 21 | - |
Interest income | ||||||||||
- | - | - | - | 0 | -2 | 2 | 0 | - | 0 | - |
Other loss (income) | ||||||||||
-350 | -36 | -239 | 2,650 | 376 | -11,612 | -1,995 | 304 | - | -40 | - |
Weighted average number of shares | ||||||||||
- | - | - | - | - | - | 29,667 | 13,232 | - | 8,527 | - |
Operating Loss | ||||||||||
- | - | - | - | - | - | - | - | -18 | - | -33 |
Net loss for the period | ||||||||||
8,048 | 11,138 | 8,081 | 8,864 | - | - | -8,290 | -2,400 | -18 | -1,333 | -33 |
Computation of basic loss per share | ||||||||||
Currency translation adjustment | ||||||||||
- | - | - | - | - | - | - | - | 0 | - | -0 |
Comprehensive Loss | ||||||||||
- | - | - | - | - | - | - | - | -18 | - | -33 |
Basic and fully diluted loss per share | ||||||||||
- | - | - | - | - | - | -0.28 | -0.18 | 0.00 | -0.16 | 0.00 |
Net loss for the period | ||||||||||
8,048 | 11,138 | 8,081 | 8,864 | - | - | -8,290 | -2,400 | -18 | -1,333 | -33 |
Series B Preferred stock dividend | ||||||||||
-80 | -176 | -790 | -238 | - | - | - | - | - | - | - |
Translation to US dollar presentation currency | ||||||||||
- | - | - | - | - | - | 0 | -21 | - | 40 | - |
Net and comprehensive loss for the period | ||||||||||
- | - | - | - | -4,347 | -6,358 | -8,290 | -2,421 | - | -1,292 | - |
Net and comprehensive loss for the period | ||||||||||
- | - | - | - | -4,347 | -6,358 | -8,290 | -2,421 | - | -1,292 | - |
Net loss for the period attributable to common stockholders | ||||||||||
8,128 | 11,314 | 8,872 | 9,103 | - | - | - | - | - | - | - |
Basic and fully diluted loss per share | ||||||||||
3.16 | 5.42 | 0.74 | 0.83 | 0.46 | -0.20 | - | - | - | - | - |
Diluted loss (income) per share | ||||||||||
- | - | - | - | - | 0.00 | - | - | - | - | - |
Basic and fully diluted number of shares | ||||||||||
2,574 | 2,086 | 12,047 | 10,948 | 9,516 | 31,969 | - | - | 3,135 | - | 5,950 |
Diluted weighted average number of shares | ||||||||||
- | - | - | - | - | 39,090 | - | - | - | - | - |